Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06863376
What this trial is testing

Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Tanta University 46
Testing effectiveness (Phase 2)Study completedNCT02443116
What this trial is testing

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
NGM Biopharmaceuticals, Inc 254
Not applicableStudy completedNCT00586885
What this trial is testing

Effects of Alanine in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Keith D Lindor, M.D. 9
Testing effectiveness (Phase 2)Looking for participantsNCT05832229
What this trial is testing

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Who this might be right for
CirrhosisCirrhosis, LiverCirrhosis Early+5 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 256
Not applicableWithdrawnNCT07255781
What this trial is testing

Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy

Who this might be right for
Psoriasis (PsO)PsA (Psoriatic Arthritis)NAFLD (Nonalcoholic Fatty Liver Disease)
University of California, San Diego
Early research (Phase 1)Study completedNCT05090111
What this trial is testing

ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Aligos Therapeutics 98
Not applicableStudy completedNCT03319199
What this trial is testing

The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver

Who this might be right for
Fatty Liver, Nonalcoholic
Rawi Hazzan 22
Not applicableStudy completedNCT03084328
What this trial is testing

Vitamin D Replacement in Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver
The Cleveland Clinic 48
Not applicableStudy completedNCT02951546
What this trial is testing

Metabolic Flexibility, Gut Microbiota, Healthy Diet and Exercise in NAFLD on Genetics Base

Who this might be right for
Non-alcoholic Fatty Liver DiseaseObesity
University of Roma La Sapienza 120
Early research (Phase 1)UnknownNCT06400771
What this trial is testing

Safety of DNP007 in Healthy Subjects

Who this might be right for
Liver Transplant RejectionLiver Transplant; ComplicationsSteatohepatitis, Nonalcoholic
Seoul National University Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00799578
What this trial is testing

A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Fatty Liver
Joel Lavine 13
Not applicableStudy completedNCT03366987
What this trial is testing

Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese Population

Who this might be right for
Nonalcoholic Fatty Liver DiseaseAtrial FibrillationCross-sectional Study
Ningbo No. 1 Hospital 2,000
Early research (Phase 1)Study completedNCT02394353
What this trial is testing

Impact of Bariatric Surgery on the Evolution of Nonalcoholic Fatty Liver Disease: a Comparative Clinical Trial Between Sleeve Gastrectomy and Gastric Bypass

Who this might be right for
ObesityFatty Liver
Ministry of Health, Brazil 60
Testing effectiveness (Phase 2)Study completedNCT03486899
What this trial is testing

Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Who this might be right for
Liver FibrosisNonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis
Bristol-Myers Squibb 197
Testing effectiveness (Phase 2)Study completedNCT03963921
What this trial is testing

Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Cellaion SA 23
Not applicableUnknownNCT04653103
What this trial is testing

NASH in Subjects With Different Classes of Obesity

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNAFLDObesity+1 more
Catholic University of the Sacred Heart 500
Early research (Phase 1)Study completedNCT04808154
What this trial is testing

A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of SNP-630 in Health Subjects.

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Sinew Pharma Inc. 28
Testing effectiveness (Phase 2)Study completedNCT05010070
What this trial is testing

The University of Michigan Wellness for Liver Health Study

Who this might be right for
Nonalcoholic Fatty Liver Disease
University of Michigan 11
Not applicableUnknownNCT05822622
What this trial is testing

Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.

Who this might be right for
Heart Failure With Preserved Ejection FractionNon Alcoholic Fatty Liver
Sohag University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07242222
What this trial is testing

Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
Tanta University 50
Next Page